JPWO2020174690A1 - - Google Patents

Info

Publication number
JPWO2020174690A1
JPWO2020174690A1 JP2021501521A JP2021501521A JPWO2020174690A1 JP WO2020174690 A1 JPWO2020174690 A1 JP WO2020174690A1 JP 2021501521 A JP2021501521 A JP 2021501521A JP 2021501521 A JP2021501521 A JP 2021501521A JP WO2020174690 A1 JPWO2020174690 A1 JP WO2020174690A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021501521A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020174690A1 publication Critical patent/JPWO2020174690A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A61K39/018—Babesia antigens, e.g. Theileria antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
JP2021501521A 2019-02-25 2019-02-25 Pending JPWO2020174690A1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2019/008255 WO2020174690A1 (ja) 2019-02-25 2019-02-25 バベシア原虫の表面抗原タンパク質、バベシア原虫に対する抗体の検出方法、バベシア症の診断方法

Publications (1)

Publication Number Publication Date
JPWO2020174690A1 true JPWO2020174690A1 (ja) 2020-09-03

Family

ID=72239740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021501521A Pending JPWO2020174690A1 (ja) 2019-02-25 2019-02-25

Country Status (2)

Country Link
JP (1) JPWO2020174690A1 (ja)
WO (1) WO2020174690A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022215742A1 (ja) * 2021-04-09 2022-10-13

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007527707A (ja) * 2003-09-14 2007-10-04 ユニバーシテイ・ユトレヒト・ホールデイング・ベー・ベー ピロプラスミドワクチン

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007527707A (ja) * 2003-09-14 2007-10-04 ユニバーシテイ・ユトレヒト・ホールデイング・ベー・ベー ピロプラスミドワクチン

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ABOGE, G. O. ET AL., MOLECULAR CHARACTERIZATION AND EXPRESSION OF A47-KDA MEROZOITE SURFACE PROTEIN, JPN6019019210, ISSN: 0005092404 *
DATABASE UNIPROT, [ONLINE], ACCESSION NO. A0A221SSH4, 07-NOV-2018, JPN6019019213, ISSN: 0005092407 *
DATABASE UNIPROT, [ONLINE], ACCESSION NO. L0B1N1, 05-DEC-2018, JPN6019019214, ISSN: 0005092408 *
IRWIN, P. J., 総説 犬バベシア症：分子分類学から疾病管理まで, 小動物臨床, 2010, VOL.29, NO.2, PP.89-, JPN6019019215, ISSN: 0005092409 *
VERDIDA, R. A. ET AL., SERODIAGNOSIS OF BABESIA GIBSONI INFECTION IN DOGS BY AN IMPROVED ENZYME-LINK, JPN6019019211, ISSN: 0005092405 *
ZHOU, J. ET AL., CHARACTERIZATION OF THE BABESIA GIBSONI P18 AS A HOMOLOGUE OF THROMBOSPONDIN RELATE, JPN6019019212, ISSN: 0005092406 *

Also Published As

Publication number Publication date
WO2020174690A1 (ja) 2020-09-03

Similar Documents

Publication Publication Date Title
BR112021018450A2 (ja)
BR112021017939A2 (ja)
BR112019016141A2 (ja)
BR112021017738A2 (ja)
BR112021017782A2 (ja)
BR112019016138A2 (ja)
BR112021018168A2 (ja)
BR112021017728A2 (ja)
BR112021018452A2 (ja)
BR112021017234A2 (ja)
BR112021017355A2 (ja)
BR112021017703A2 (ja)
BR112021017173A2 (ja)
BR112021018102A2 (ja)
BR112021017083A2 (ja)
BR112021017637A2 (ja)
BR112021018250A2 (ja)
BR112021018084A2 (ja)
BR112021018093A2 (ja)
BR112021018484A2 (ja)
BR112021017732A2 (ja)
BR112021015080A2 (ja)
BR112021017949A2 (ja)
BR112021017983A2 (ja)
BR112021016205A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210914

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230110

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230309

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230627